Comment from American Association of Pharmaceutical Scientists (AAPS)

Summary: The American Association of Pharmaceutical Scientists provides detailed feedback on the draft guidance for QSP-based dose selection in FIH trials. They support the guidance but recommend specific revisions to clarify definitions of biological effects, model complexity, validation approaches, and reproducibility requirements for submitted code.